20-22582142-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021784.5(FOXA2):āc.1100A>Cā(p.Glu367Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000197 in 1,577,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 33)
Exomes š: 0.000020 ( 0 hom. )
Consequence
FOXA2
NM_021784.5 missense
NM_021784.5 missense
Scores
2
7
10
Clinical Significance
Conservation
PhyloP100: 6.20
Genes affected
FOXA2 (HGNC:5022): (forkhead box A2) This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific genes such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. This gene has been linked to sporadic cases of maturity-onset diabetes of the young. Transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.11932984).
BS2
High AC in GnomAdExome4 at 28 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXA2 | NM_021784.5 | c.1100A>C | p.Glu367Ala | missense_variant | 2/2 | ENST00000419308.7 | NP_068556.2 | |
FOXA2 | NM_153675.3 | c.1082A>C | p.Glu361Ala | missense_variant | 3/3 | NP_710141.1 | ||
FOXA2 | XM_047440133.1 | c.1082A>C | p.Glu361Ala | missense_variant | 3/3 | XP_047296089.1 | ||
FOXA2 | XM_047440134.1 | c.992A>C | p.Glu331Ala | missense_variant | 2/2 | XP_047296090.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXA2 | ENST00000419308.7 | c.1100A>C | p.Glu367Ala | missense_variant | 2/2 | 1 | NM_021784.5 | ENSP00000400341 | P4 | |
FOXA2 | ENST00000377115.4 | c.1082A>C | p.Glu361Ala | missense_variant | 3/3 | 1 | ENSP00000366319 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152148Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152148
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000596 AC: 11AN: 184662Hom.: 0 AF XY: 0.0000709 AC XY: 7AN XY: 98782
GnomAD3 exomes
AF:
AC:
11
AN:
184662
Hom.:
AF XY:
AC XY:
7
AN XY:
98782
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000197 AC: 28AN: 1424758Hom.: 0 Cov.: 35 AF XY: 0.0000255 AC XY: 18AN XY: 705320
GnomAD4 exome
AF:
AC:
28
AN:
1424758
Hom.:
Cov.:
35
AF XY:
AC XY:
18
AN XY:
705320
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74450
GnomAD4 genome
AF:
AC:
3
AN:
152266
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
7
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.1100A>C (p.E367A) alteration is located in exon 2 (coding exon 2) of the FOXA2 gene. This alteration results from a A to C substitution at nucleotide position 1100, causing the glutamic acid (E) at amino acid position 367 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;L
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.82
.;P
Vest4
MutPred
0.20
.;Loss of solvent accessibility (P = 0.0442);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at